Page 68 - TD-2-3

Tumor Discovery Ureteral IgG4-related disease in urology

3. Zykova A, Novikov P, Brovko M, et al., 2020, IgG4-related https://doi.org/10.1097/MD.0000000000002550
disease: The state of art. Clin Pharmacol Ther, 29(3): 4–13. 13. Zhong W, Kam J, Beattie K, et al., 2018, A rare case of
(In Russ).
ureteral IgG4 disease masquerading as urothelial carcinoma.
https://doi.org/10.32756/0869-5490-2020-3-4-13 Urology, 118: e1–e2.
4. Kamisawa T, Funata N, Hayashi Y, et al., 2003, A new https://doi.org/10.1016/j.urology.2018.05.019
clinicopathological entity of IgG4-related autoimmune 14. Bissada NK, Finkbeiner AE, 1978, Idiopathic segmental
disease. J Gastroenterol, 38(10): 982–984.
ureteritis. Urology, 12(1): 64–66.
https://doi.org/10.1007/s00535-003-1175-y
https://doi.org/10.1016/0090-4295(78)90370-9
5. Umehara H, Okazaki K, Masaki Y, et al., 2012, A novel 15. Ueki Т, Miyake T, Narita M, et al., 2020, IgG4-related focal
clinical entity, IgG4-related disease (IgG4RD): General retroperitoneal fibrosis in ureter suggestive of colon cancer
concept and details. Mod Rheumatol, 22(1): 1–14.
recurrence and resected laparoscopically: A case report.
https://doi.org/10.1007/s10165-011-0508-6 Surg Case Rep, 6: 197.
6. Deshpande V, Zen Y, Chan JK, et al., 2012, Consensus https://doi.org/10.1186/s40792-020-00964-0
statement on the pathology of IgG4-related disease. Mod 16. Williams IS, Wang N, Bergamin P, et al., 2021, Peri-ureteric
Pathol, 25: 1181–1192.
mass an unusual case of immunoglobin G4-related disease
https://doi.org/10.1038/modpathol.2012.72 (IgG4-RD). Urol Case Rep, 38: 101666.
7. Yu KH, Chan TM, Tsai PH, et al., 2015, Diagnostic https://doi.org/10.1016/j.eucr.2021.101666
performance of serum IgG4 levels in patients with 17. Lanzillotta M, Mancuso G, Della-Torre E, 2020, Advances in
IgG4-related disease. Medicine (Baltimore), 94: e1707.
the diagnosis and management of IgG4 related disease. BMJ,
https://doi.org/10.1097/MD.0000000000001707 369: m1067.
8. Vasaitis L, 2016, IgG4-related disease: A relatively new https://doi.org/10.1136/bmj.m1067
concept for clinicians. Eur J Inter Med, 27: 1–9.
18. Ebbo M, Grados A, Samson M, et al., 2017, Long-term
https://doi.org/10.1016/j.ejim.2015.09.022 efficacy and safety of rituximab in IgG4-related disease: Data
from a French nationwide study of thirty-three patients.
9. Wallace ZS, Zhang Y, Perugino CA, et al., 2019, Clinical
phenotypes of IgG4-related disease: An analysis of two PLoS One, 12(9): e0183844.
international cross-sectional cohorts. Ann Rheum Dis, https://doi.org/10.1371/journal.pone.0183844
78(3): 406–412.
19. Campochiaro C, Della-Torre E, Lanzillotta M, et al., 2020,
https://doi.org/10.1136/annrheumdis-2018-214603 Long-term efficacy of maintenance therapy with rituximab
for IgG4-related disease. Eur J Intern Med, 74: 92–98.
10. Teng F, Lu H, Zheng K, et al., 2020, Urinary system
manifestation of IgG4-related disease: Clinical, laboratory, https://doi.org/10.1016/j.ejim.2019.12.029
radiological, and pathological spectra of a Chinese single- 20. Buijs J, van Heerde MJ, Rauws EA, et al., 2014, Comparable
centre study. J Immunol Res, 2020: 5851842.
efficacy of low-versus high-dose induction corticosteroid
https://doi.org/10.1155/2020/5851842 treatment in autoimmune pancreatitis. Pancreas, 43(2):
261–267.
11. Bianchi D, 2016, IgG4-related disease: What urologists
should know. Int Urol Nephrol, 48(3): 301–312. https://doi.org/10.1097/MPA.0000000000000044
https://doi.org/10.1007/s11255-015-1189-4 21. Tang J, Cai S, Ye C, et al., 2020, Biomarkers in IgG4-related
disease: A systematic review. Semin Arthritis Rheum,
12. Lei WH, Xin J, Shao CX, et al., 2016, IgG4-related kidney
disease mimicking malignant ureter tumor: Case report and 50(2):354–359.
literature review. Medicine (Baltimore), 95(3): e2550. https://doi.org/10.1016/j.semarthrit.2019.06.018

Volume 2 Issue 3 (2023) 7 https://doi.org/10.36922/td.1766